Search

Your search keyword '"Shovanlal Gayen"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Shovanlal Gayen" Remove constraint Author: "Shovanlal Gayen"
134 results on '"Shovanlal Gayen"'

Search Results

1. Identification of structural features of surface modifiers in engineered nanostructured metal oxides regarding cell uptake through ML-based classification

2. Inonotus obliquus aqueous extract prevents histopathological alterations in liver induced by environmental toxicant Microcystin

4. Structure of the C-terminal Region of the Frizzled Receptor 1 in Detergent Micelles

8. Recent Developments on Synthesis of Organofluorine Compounds Using Green Approaches

11. A critical analysis of urea transporter B inhibitors: molecular fingerprints, pharmacophore features for the development of next-generation diuretics

12. First molecular modelling report on tri-substituted pyrazolines as phosphodiesterase 5 (PDE5) inhibitors through classical and machine learning based multi-QSAR analysis

13. Monte Carlo Optimization-Based QSAR Study of Some Indole-Based Mcl-1 Inhibitors

14. Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery

15. First structure–activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery

17. Recent Developments on Synthesis of Indole Derivatives Through Green Approaches and Their Pharmaceutical Applications

18. Identification of structural fingerprints for ABCG2 inhibition by using Monte Carlo optimization, Bayesian classification, and structural and physicochemical interpretation (SPCI) analysis

19. Identification of structural fingerprints for in vivo toxicity by using Monte Carlo based QSTR modeling of nitroaromatics

20. Understanding the correlation between structure and dynamics of clocortolone pivalate by solid state NMR measurement

21. Exploring indole derivatives as myeloid cell leukaemia-1 (Mcl-1) inhibitors with multi-QSAR approach: a novel hope in anti-cancer drug discovery

22. In silico modelling, identification of crucial molecular fingerprints, and prediction of new possible substrates of human organic cationic transporters 1 and 2

23. Investigation of the Detailed Internal Structure and Dynamics of Itraconazole by Solid-State NMR Measurements

24. How the structural properties of the indole derivatives are important in kinase targeted drug design?: A case study on tyrosine kinase inhibitors

25. Recent trends in fragment-based anticancer drug design strategies against different targets: A mini-review

26. A review of MMP-2 structures and binding mode analysis of its inhibitors to strategize structure-based drug design

28. Urea transporter and its specific and nonspecific inhibitors: State of the art and pharmacological perspective

29. 2-Phenylindole derivatives as anticancer agents: synthesis and screening against murine melanoma, human lung and breast cancer cell lines

30. Exploration of good and bad structural fingerprints for inhibition of indoleamine-2,3-dioxygenase enzyme in cancer immunotherapy using Monte Carlo optimization and Bayesian classification QSAR modeling

32. A Review on Camptothecin Analogs with Promising Cytotoxic Profile

33. Good and bad molecular fingerprints for human rhinovirus 3C protease inhibition: identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR study

34. Reliable structural information for rational design of benzoxazole type potential cholesteryl ester transfer protein (CETP) inhibitors through multiple validated modeling techniques

35. Monte Carlo based modelling approach for designing and predicting cytotoxicity of 2-phenylindole derivatives against breast cancer cell line MCF7

36. Updated chemical scaffolds of ABCG2 inhibitors and their structure-inhibition relationships for future development

37. Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors

38. Biopolymeric hydrogels prepared via click chemistry as carriers of therapeutic modalities

39. List of contributors

40. Structure and dynamics of sodium alginate as elucidated by chemical shift anisotropy and site-specific spin-lattice relaxation time measurements

41. Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?

42. Exploring sodium glucose cotransporter (SGLT2) inhibitors with machine learning approach: A novel hope in anti-diabetes drug discovery

43. Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery

44. Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors

45. An atomic resolution description of folic acid using solid state NMR measurements

46. Identification of structural fingerprints for in vivo toxicity by using Monte Carlo based QSTR modeling of nitroaromatics

48. Identification of structural fingerprints for

49. First Report on the Validated Classification-Based Chemometric Modeling of Human Rhinovirus 3C Protease (HRV 3Cpro) Inhibitors

50. Structure-activity relationship of human carbonic anhydrase-II inhibitors: Detailed insight for future development as anti-glaucoma agents

Catalog

Books, media, physical & digital resources